Pediapharm Stock Price, News & Analysis (CVE:PDP)

C$0.29 -0.01 (-3.33 %)
(As of 03/19/2018 02:26 AM ET)
Previous CloseC$0.29
Today's RangeC$0.28 - C$0.30
52-Week RangeC$0.25 - C$0.35
Volume72,000 shs
Average Volume134,017 shs
Market CapitalizationC$28.85 million
P/E Ratio-5.80
Dividend YieldN/A

About Pediapharm (CVE:PDP)

Pediapharm Inc. (Pediapharm) is a specialty pharmaceutical company. The Company distributes prescription medicines used to treat pathological conditions that mainly affect children from infancy to 18 years of age. The Company sells products and offers marketing services to the pharmaceutical industry, particularly related to pediatric care. It offers NYDA, a treatment indicated for eradication of head lice and its eggs. The products that the Company distributes originate from transactions whereby Pediapharm acquires intellectual property rights through a licensing agreement that enables Pediapharm to register the drug products with Health Canada in order to commercialize them. Pediapharm does not produce, manufacture or develop products, but rather licenses finished products and sells them. Pediapharm also commercializes non-prescription products (non-prescription drugs, medical devices, diagnostic products). The Company's subsidiary is Pediapharm Licensing Inc.

Receive PDP News and Ratings via Email

Sign-up to receive the latest news and ratings for PDP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio-5.8
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSC($0.05)
Net IncomeN/A
Net Margins-10.92%
Return on Equity-26.38%
Return on Assets-11.84%


Outstanding Shares87,415,000

Pediapharm (CVE:PDP) Frequently Asked Questions

What is Pediapharm's stock symbol?

Pediapharm trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PDP."

When will Pediapharm make its next earnings announcement?

Pediapharm is scheduled to release their next quarterly earnings announcement on Wednesday, June, 27th 2018. View Earnings Estimates for Pediapharm.

Who are some of Pediapharm's key competitors?

Who are Pediapharm's key executives?

Pediapharm's management team includes the folowing people:

  • Pierre Lapalme, Chairman of the Board (Age 76)
  • Sylvain Chretien, President, Chief Executive Officer, Director
  • Roland Boivin, Chief Financial Officer
  • Richard Labelle, Vice President - Sales and Marketing
  • Benoit Hebert, Vice President - Business Development & Licensing
  • Benoit Gravel, Director

Has Pediapharm been receiving favorable news coverage?

News articles about PDP stock have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Pediapharm earned a coverage optimism score of 0.11 on Accern's scale. They also gave news headlines about the company an impact score of 46.34 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Pediapharm?

Shares of PDP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Pediapharm's stock price today?

One share of PDP stock can currently be purchased for approximately C$0.29.

How big of a company is Pediapharm?

Pediapharm has a market capitalization of C$28.85 million.

How can I contact Pediapharm?

Pediapharm's mailing address is 1 du Commerce Pl Suite 225, VERDUN, QC H3E 1A2, Canada. The company can be reached via phone at +1-514-7622626.

MarketBeat Community Rating for Pediapharm (PDP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  18 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about Pediapharm and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pediapharm (CVE:PDP) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Pediapharm (CVE:PDP) Earnings History and Estimates Chart

Earnings by Quarter for Pediapharm (CVE:PDP)

Pediapharm (CVE PDP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/24/2017Q1 2018C($0.01)C($0.01)C$2.00 millionC$2.47 millionViewN/AView Earnings Details
6/28/2017Q4 2017C($0.02)C($0.02)C$1.50 millionC$1.66 millionViewN/AView Earnings Details
2/28/2017Q3 2017C($0.01)C($0.01)C$1.77 millionViewN/AView Earnings Details
11/28/2016Q2 2017C($0.01)C$1.88 millionViewN/AView Earnings Details
8/18/2016Q1 2017C$0.02C$0.89 millionViewN/AView Earnings Details
6/27/2016Q4 2016C($0.02)C$0.65 millionViewN/AView Earnings Details
2/25/2016Q3 2016C($0.02)C$1.02 millionViewN/AView Earnings Details
11/30/2015Q2 2016C($0.01)C$1.47 millionViewN/AView Earnings Details
8/27/2015Q1 2016C($0.02)C$0.61 millionViewN/AView Earnings Details
7/20/2015Q4 2015C($0.03)C$0.34 millionViewN/AView Earnings Details
3/2/2015Q3 2015C($0.02)C$0.92 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Pediapharm (CVE:PDP) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Pediapharm (CVE:PDP)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Pediapharm (CVE PDP)

No insider trades for this company have been tracked by


Pediapharm (CVE PDP) News Headlines

Pediapharm Inc. (PDP) Scheduled to Post Earnings on WednesdayPediapharm Inc. (PDP) Scheduled to Post Earnings on Wednesday - August 9 at 7:22 AM

SEC Filings

Pediapharm (CVE:PDP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Pediapharm (CVE PDP) Stock Chart for Monday, March, 19, 2018

Loading chart…

This page was last updated on 3/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.